Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Malignant Neoplasm × Infusions, Intravenous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2 Solid Tumors 1 Recurrence 1 Myelodysplastic Syndromes 1 Metastatic Solid Tumors 1 Leukemia, Myelomonocytic, Chronic 1 Advanced Malignant Neoplasm 1

Interventions

Infusions, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05048160 2022-05-09

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡